Evidence map›Paper›PMID 38539437›Full record

ArticleCancers2024

Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020.

Robert C Hsu, Kai-Ya Tsai, David J Benjamin, Krithika Chennapan, Katherine Y Wojcik, Alice W Lee, Jacob S Thomas, Jorge J Nieva, Lihua Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Robert C HsuDepartment of Internal Medicine, Division of Medical Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.ORCID 0000-0003-3957-6106
Kai-Ya TsaiDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.ORCID 0009-0002-7078-4114
David J BenjaminHoag Family Cancer Institute, Newport Beach, CA 92663, USA.
Krithika ChennapanDepartment of Internal Medicine, Division of Medical Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Katherine Y WojcikDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Alice W LeeDepartment of Public Health, California State University, Fullerton, CA 92831, USA.ORCID 0000-0001-8756-7066
Jacob S ThomasDepartment of Internal Medicine, Division of Medical Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Jorge J NievaDepartment of Internal Medicine, Division of Medical Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Lihua LiuDepartment of Internal Medicine, Division of Medical Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
University of Southern California · USCalifornia State University, Fullerton · USHoag Memorial Hospital Presbyterian · US

Funding

NCI NIH HHS HHSN261201800015I
6 · The paper itself

Abstract

backgroundPrevious studies on Hispanic thyroid cancer cases show sex disparities and an increased prevalence of large tumor sizes and nodal involvement. Here, we characterized Hispanic thyroid cancer cases in California.

methodsWe identified thyroid cancer cases from 2010 to 2020 using the California Cancer Registry by sex, race/ethnicity, histology, TNM stage, tumor size, lymph node involvement, and Charlson comorbidity score. The age-adjusted incidence rate (AAIR) and age-adjusted mortality rate (AAMR) for all causes of death were calculated. A Cox proportional hazards regression analysis was performed to evaluate the mortality risk from all causes of death by race.

resultsOverall, 56,838 thyroid cancer cases were identified, including 29.75% in Hispanics. Hispanics had the highest female-to-male incidence rate ratio (IRR 3.54) and the highest prevalence of T3/T4 tumor size (28.71%), the highest N1 nodal status (32.69%), and the highest AAMR (0.79 per 100,000 people). After adjusting for demographic and tumor covariates, compared to non-Hispanic White people, Hispanic ethnicity, with an HR of 1.22 (95% CI 1.18-1.25,

conclusionsHispanics had the greatest female-to-male IRR ratio, a greater prevalence of advanced disease features at diagnosis, along with the highest AAMR and increased mortality risk despite adjustments for demographic and tumor covariates. Further investigation into other risk factors is needed.

Indexed as

cancer disparitiesepidemiologyHispanicsrisk factorsthyroid cancer

Identifiers

PMID38539437
PMCPMC10969047
OpenAlexW4392654789

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.